,

Fragment-Based Drug Discovery and X-Ray Crystallography

Specificaties
Gebonden, 228 blz. | Engels
Springer Berlin Heidelberg | 2012e druk, 2012
ISBN13: 9783642275395
Rubricering
Juridisch :
Springer Berlin Heidelberg 2012e druk, 2012 9783642275395
Onderdeel van serie Topics in Current Chemistry
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson

Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle

Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard

Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford

Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber

Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvönen

Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold

Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan

Specificaties

ISBN13:9783642275395
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:228
Uitgever:Springer Berlin Heidelberg
Druk:2012

Inhoudsopgave

<p>D. A. Erlanson<br>Introduction to Fragment-Based Drug Discovery.- </p><p>T. G. Davies<br>Ian J. Tickle<br>Fragment Screening Using X-Ray Crystallography.- </p><p>S. Roughley<br>L. Wright<br>P. Brough<br>A. Massey <br>R. E. Hubbard<br>Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening.- </p><p>D. F. Wyss<br>Y.-S. Wang<br>H. L. Eaton<br>C. Strickland<br>J.s H. Voigt<br>Z. Zhu <br>A. W. Stamford<br>Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors.- </p><p>M. Hennig<br>A. Ruf <br>Walter HuberCombining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery.- </p><p>E. Valkov<br>T. Sharpe<br>M. Marsh<br>Sa. Greive <br>M. Hyvönen<br>Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery.- </p><p>J.h D. Bauman<br>D. Patel <br>E. Arnold<br>Fragment Screening and HIV Therapeutics.- </p><p>D. Rognan<br>Fragment-Based Approaches and Computer-Aided Drug Discovery.</p><p>

Net verschenen

Rubrieken

    Personen

      Trefwoorden

        Fragment-Based Drug Discovery and X-Ray Crystallography